Glycine mollis

Human medicines European public assessment report (EPAR): Flixabi, infliximab, Date of authorisation: 26/05/2016, Revision: 24, Status: Authorised

• View the full release here: https://www.businesswire.com/news/home/20230804756518/en/
  Nitika, living with moderate to severe plaque psoriasis.
• (Photo: Bristol Myers Squibb)
  “I was young when I was diagnosed with moderate to severe plaque psoriasis, and it felt like my whole life revolved around my condition.
• “This insight drove us to launch the Clear Understanding campaign to recognize those concessions and encourage people living with moderate to severe plaque psoriasis to talk to their dermatologist about available treatment options."
• In two studies of moderate to severe plaque psoriasis, Sotyktu was compared to placebo and Otezla® (apremilast).

• This exciting development brings new and innovative laser treatments to his practice; benefiting patients with enhanced precision, comfort, and effectiveness.
• The CO2 laser, handcrafted in Italy, is renowned worldwide for its versatility and exceptional performance in various medical fields.
• Dr. Choorapuzha is proud to bring this state-of-the-art laser technology to his dental practice, allowing patients to experience the advantages of advanced laser treatments.
• "We are excited to share the new and advanced laser technology we recently added to the practice to benefit our patients," said Dr. Choorapuzha.

• CMV belongs to the same virus family as cold sores and chickenpox and, like those viruses, lives in the body for life.
• Most children and adults experience very mild or even no symptoms with their initial infection.
• Congenital CMV, or cCMV, is the most common infection before birth and the leading infectious cause of birth defects.
• Black and Native American infants also have a higher risk of death from cCMV compared to white infants.

Looking for CMV during pregnancy

• If CMV can infect a fetus and cause birth defects, then why aren’t pregnant people tested and treated for this virus too?
• Prenatal CMV screening is not standard of care due to several limitations of the current testing approach.
• Biweekly antibodies against CMV seem to reduce fetal transmission when given around conception or during the first trimester, but CMV is rarely diagnosed that early in pregnancy.
• In general, valacyclovir does not work as well as other CMV drugs that people cannot take during pregnancy.

Screening newborns for CMV

• An accurate CMV test for newborns is available, and many studies support the benefit of early CMV diagnosis.
• While some birth centers provide early CMV testing, most U.S. states do not mandate newborn CMV screening.
• In February 2022, Minnesota became the first – and remains the only – state to require CMV screening of all newborns, although Massachusetts and Indiana have pending universal screening bills.
• Most newborns with cCMV appear physically normal at birth and develop normally over their lifetime, leading some to question the benefits of CMV screening for those children.

Spreading CMV awareness, not infection

• Most people have not heard of CMV or are unwaware of what they can do to reduce their chances of getting CMV during pregnancy.
• Many adults are repeatedly exposed to one of the major risk factors for CMV infection: a young child who regularly attends large-group child care.
• Children can appear quite healthy but carry CMV in their saliva and urine for weeks or even months after infection.